DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,640
+1,510 (9.98%)
At close: Feb 27, 2026
Market Cap291.48B +63.0%
Revenue (ttm)149.47B +1.1%
Net Income39.73M
EPS2.27
Shares Out17.52M
PE Ratio7,337.11
Forward PEn/a
Dividend150.00 (0.90%)
Ex-Dividend DateDec 29, 2025
Volume1,714,109
Average Volume179,788
Open18,470
Previous Close15,130
Day's Range16,200 - 18,620
52-Week Range10,330 - 24,900
Beta-0.30
RSI58.81
Earnings DateFeb 6, 2026

About DAE HWA Pharmaceutical

DAE HWA Pharmaceutical Co., Ltd., a pharmaceutical company, produces and supplies pharmaceutical products in South Korea. The company offers drugs for anticancer, antibiotics, antifungal and skin ailment, antivirus, anti-allergosis, hemorrhoids, antidepressant, antiepileptic, psychotropic agent, anti respiratory, anti-inflammatory, analgesic, skeletal muscle relaxants, osteoporosis, anti-arthritis, gastro-intestinal, obesity, antispasmodic, diabetics, hypertension, hyperlipemia, antithrombotic and anticoagulant, hepatic, erectile dysfunction, u... [Read more]

Industry Pharmaceutical Preparations
Founded 1984
Employees 308
Stock Exchange KOSDAQ
Ticker Symbol 067080
Full Company Profile

Financial Performance

Financial Statements